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A New Route to Tricyclane Sesquiterpenoids: Total Synthesis of α-
Ekasantalic acid
L. Lomba,a K. Afarinkia,b  and V. Vinaderb 
Chemical manipulation of the cycloadduct of citraconic anhydride and cyclopentadiene enables a new synthetic route to 
tricyclane sesquiterpenoids. This methodology is applied to the first total synthesis of α-ekasantalic acid.
Introduction
Tricyclane sesquiterpenoids (Figure 1) are a family of nearly 
100 natural products isolated from plant sources. The principle 
characteristic feature of this natural product family is the 
presence of a tricyclo[2.2.1.02,6]heptane (tricyclane) ring within 
their structure. α-Santalene, 1,1-3 and its analogues, e.g. 2-4,4-7 
represent the most common skeleton in this family, although 
other skeletons, as exemplified by cyclosinularane, 5,8 
cycloseychellene, 6,9 and cyclomyltaylan-5α-ol, 7,10,11 are also 
reported. A handful of molecules in this family contain a fourth 
ring leading to compact and complex skeletons comprising of 
several quaternary carbon atoms. These include longicyclene, 
8,12,13 and it’s analogues 9,14 and 10;12,13 cyclosativene, 11,15-21 
cyclocopacamphene, 12,19,22 and dendronobilin N, 13.23 
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Figure 1 Tricyclane sesquiterpenoid family and related compounds.
Traditionally, tricyclane sesquiterpenoids’ main use has been 
in the perfumery and flavouring industries, although many 
plant extracts that do contain them have also been used in 
traditional medicine.24-26 More recently, individual molecules 
with antifungal, antibacterial and antitumor properties are 
reported in the literature. For example, α-santalol, 2, binds to 
tubulin and cause G2/M cell cycle arrest in a panel of head and 
neck cancer cell lines5 and HL-60 leukaemia cells;4 inhibits 
migration of MCF-7 and MDA-MB-231 breast cancer cells by 
targeting the ß-catenin pathway;27 and is an antagonist of D2 
and 5-HT2A receptors.28 Compound 2 is also shown to be mildly 
active against Helicobacter pylori6 whilst compound 3 is 
reported to have antimicrobial activity against the oral 
pathogen Porphyromonas gingivalis.7 Compound 4 is a pro-
apoptotic cytotoxin at sub µM concentrations,29 showing 
selectivity for tumour cells against healthy ones; and 
compound 10, a metabolite of longicyclene, suppresses the 
SOS response induced by chemical mutagens.30 
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Figure 2 Proposed synthetic route to tricyclic α-ekasantalic acid, 14, 
and to tetracyclic sesquiterpenoids.
Further understanding of the mode of action of this rare class 
of molecules, as well as their development as potential 
therapeutics, is severely hampered by the lack of robust and 
general synthetic routes to prepare them. Although there are a 
number of efficient routes to the synthesis of tricylances,31-34 
few have found application in total synthesis. In view of the 
potential biological interest in this family of compounds, we 
set out to develop a general and divergent synthetic route to 
them and in particular to synthesise versatile intermediates 
that can be used in the preparation of different targets in this 
family, including functionalised analogues of α-santalene and 
those with a fourth ring such as longicyclene, 8 and 
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cyclosativene, 11. Here we report the first total synthesis of α-
ekasantalic acid, 14,35 a constituent of East Indian sandalwood 
oil,36,37 also known as tricycloekasantalic acid in some 
literature and preparation of a number of key intermediates, 
such as 15, which can be used both in preparation of 
analogues as well as in total syntheses of other members of 
this family (Figure 2).
Results and discussion
Commercially available citraconic anhydride underwent an 
efficient Diels-Alder cycloaddition with cyclopentadiene to 
afford exclusively the endo cycloadduct 16. Treatment of 
cycloadduct 16 with sodium isopropoxide, selectively afforded 
sodium carboxylate salt 17 (Figure 3). The regioselectivity of 
the acid anhydride ring opening is most likely due to steric 
factors. The bulky isopropoxide anion avoids attacking the 
carboxyl function adjacent to the quaternary carbon atom due 
to the methyl substituent. Furthermore, under these basic 
reaction conditions, the ester group is epimerised to the less 
sterically encumbered and hence more thermodynamically 
favoured exo position. 
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Figure 3 Preparation of key intermediate 15
Treatment of 17 with bromine in water affords bromide 18. 
Reaction proceeds via formation of a bromonium cation from 
the less sterically hindered face of the alkene, followed by 
backside attack of the nucleophilic carboxylate. Treatment of 
18 with potassium tert-butoxide in tetrahydrofuran resulted in 
enolisation of the noncyclic ester, followed by intramolecular 
cyclisation and elimination of potassium bromide to give 19. 
We have previously shown that similar carbanion-initiated 
cyclisations are a facile route to tricyclanes.31
It was possible to selectively hydrolyse the non-cyclic ester in 
19 under acidic conditions to obtain 20. Presumably, under 
acidic conditions, any hydrolysis of the cyclic ester will be 
followed by facile re-esterification, since the hydroxyl and 
carboxylic groups are spatially close. Reduction of the 
carboxylic acid function in 20 with borane afforded the key 
intermediate alcohol 15 in multigram quantities in 6 steps and 
50% overall yield (Figure 3).
Next, alcohol 15 was transformed to iodide 21 which was then 
treated with lithium aluminium hydride to efficiently afford 
bisalcohol 22 (Figure 4). In addition to compound 22, hydride 
reduction of 21 also afforded compound 23 as a minor 
byproduct (2% isolated) which is obtained by conjugate 
addition of a hydride at C-1 to open the cyclopropane ring. 
Although the yield of this by product is too small for it to be a 
synthetically useful step, the production of 23 is interesting 
since chain extension at C10 would lead to β-santalene 
skeleton. 
Our next task was to selectively manipulate one of two 
hydroxyl groups in compound 22. However, all our attempts at 
selective protection of one of two hydroxyl groups in 
compound 22 were unsuccessful. These included treatment 
with Boc anhydride, benzoyl chloide and pivaloyl chloide, 
TBDMSCl, TBDMS-imidazole, and TBDPSCl. Presumably, this is 
because the primary neopentyl primary alcohol and the 
secondary alcohol functions have similar steric demand. In 
order to chemically distinguish the two hydroxyl groups, we 
converted the bisalcohol 22 to compound 24 by Swern 
oxidation, with the knowledge that aldehydes react more 
efficiently than ketones in Wittig type reactions. Gratifyingly, 
we found that the aldehyde function in compound 24 
selectively undergoes Wittig reactions. Thus, treatment of 
compound 24 with the corresponding Wittig reagent, followed 
by hydrogenation of the resulting alkene afforded 5-keto-α-
ekasantalic acid ethyl ester, 25. The reduction of the 5-keto 
group was achieved via the transformation to the thione 26, 
using Lawesson’s reagent, followed by reduction using 
(NiCl2/NaBH4) to afford 27. The hydrolysis of 27 produced α-
ekasantalic acid, 14 (Figure 4). This represents the first total 
synthesis of (±)-α-ekasantalic acid, 14. Furthermore, 
compound 27 is a known precursor in the total synthesis of α-
santalene,38 therefore this synthetic route also represents a 
formal synthesis of 1.
i) PPh3, I2, Imidazole, 83%; ii) LiAlH4, THF, reflux, 84%; iii) DMSO, Et3N, (COCl)2,
CH2Cl2, 95%; iv) Ph3P=CHCO2Et, THF, 22 h, 97%; v) H2, EtOAc, (10%)Pd/C, 100%;
vi) Lawesson's reagent, toluene reflux, 24 h, 80%; vii) NiCl2, EtOH, NaBH4, reflux, 1 h,
75%; viii) Aq. NaOH (1M), THF, 95%; viii) Ph3P=CHCOiPr, THF, 35 h, 96%.
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 Figure 4 Preparation of (±)-α-ekasantalic acid, 14.
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Conclusions
In summary, we report the first total synthesis of (±)-α-
ekasantalic acid, an unusual sesquiterpenoid containing a 
tricyclo[2.2.1.02,6]heptane (tricyclane) ring. The methodology 
we have developed, uses intermediates in which C5 bears 
functionality meaning that it can be utilised in the construction 
of a fourth ring, as present in, for example, longicyclene, 8 and 
cyclosativene, 11. Further work towards the total synthesis of 
these natural products is currently underway in our group. In 
addition, we are also investigating the biological activity of 
these compounds and their analogues and will report our 
results in due course.
Experimental
Synthetic procedures and full characterisation data are 
provided in the suporting information.
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